Growth Metrics

Conmed (CNMD) Net Cash Flow (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Conmed 1.06 Bn 1.02 Bn 183.45 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -368.23%
Dec 31, 2025 -62.73%
Sep 30, 2025 259.32%
Jun 30, 2025 -130.59%
Mar 31, 2025 186.71%
Dec 31, 2024 -231.49%
Sep 30, 2024 304.92%
Jun 30, 2024 -143.38%
Mar 31, 2024 239.39%
Dec 31, 2023 -306.22%
Sep 30, 2023 158.22%
Jun 30, 2023 149.33%
Mar 31, 2023 57.02%
Dec 31, 2022 65.38%
Sep 30, 2022 -162.47%
Jun 30, 2022 616.63%
Mar 31, 2022 140.52%
Dec 31, 2021 27.23%
Sep 30, 2021 -252.39%
Jun 30, 2021 -11.32%
Mar 31, 2021 201.92%
Dec 31, 2020 -1,597.50%
Sep 30, 2020 -106.10%
Jun 30, 2020 4,624.42%
Mar 31, 2020 95.62%
Dec 31, 2019 -159.67%
Sep 30, 2019 867.74%
Jun 30, 2019 -117.78%
Mar 31, 2019 152.01%
Dec 31, 2018 -284.28%
Sep 30, 2018 90.29%
Jun 30, 2018 127.67%
Mar 31, 2018 -4.62%
Dec 31, 2017 -504.24%
Sep 30, 2017 -26.08%
Jun 30, 2017 -40.18%
Mar 31, 2017 214.54%
Dec 31, 2016 -36.96%
Sep 30, 2016 -26.56%
Jun 30, 2016 108.30%
Mar 31, 2016 -762.50%
Dec 31, 2015 39.27%
Sep 30, 2015 212.06%
Jun 30, 2015 -198.04%
Mar 31, 2015 12.37%
Dec 31, 2014 -44.39%
Sep 30, 2014 158.68%
Jun 30, 2014 85.68%
Mar 31, 2014 -64.11%
Dec 31, 2013 -53.73%
Sep 30, 2013 55.42%
Jun 30, 2013 -24.33%
Mar 31, 2013 53.23%
Dec 31, 2012 37.74%
Sep 30, 2012 276.25%
Jun 30, 2012 65.99%
Mar 31, 2012 47.65%
Dec 31, 2011 -178.36%
Sep 30, 2011 186.48%
Jun 30, 2011 26.51%
Mar 31, 2011 231.21%
Dec 31, 2010 -153.39%